ACTIVITY NUMBER: RES015
ACTIVITY TITLE: Evaluation of the Climacteric
ACCREDITATION STATEMENT
The American Society for Reproductive Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Release Date: November 1, 2012
Reviewed and Updated in 2015
Reviewed and Updated
Expiration Date: October 31, 2021
Under Review July 2022
Estimated Time to Complete Activity: 1.0 hour
NEEDS ASSESSMENT and IDENTIFICATION OF PRACTICE GAP
More than 1.5 million women reach menopause each year in the United States. The menopausal transition is a relatively unpredictable time of life and more than 85% of women will experience at least one symptom of menopause. The physiological transition includes a multitude of changes including vasomotor symptoms, sleep disturbances, mood fluctuations, cognitive changes, and sexual dysfunction, along with increased risk for osteoporosis and cardiovascular disease. Physicians play an important role in eliciting menopausal symptoms, using laboratory testing appropriately and providing patients with accurate information about menopause and its management. In a 2008 survey of practicing reproductive care physicians only 36% correctly associated symptoms within the menopausal transition. In this presentation, clinicians will learn about the wide variety of menopause-related symptoms, their causes, modifiers, and assessments. Other age-appropriate risk assessments and screenings will also be discussed.
This educational activity is designed to address the Unit 5 Reproductive Endocrinology educational objectives from the Council on Resident Education in Obstetrics and Gynecology (CREOG) on this topic.
EDUCATIONAL OBJECTIVES
At the conclusion of the educational activity, participants should be able to:
1. Describe typical symptoms experienced by a woman at the time of menopause.
2. List the essential components of a focused physical examination of a menopausal patient.
3. Interpret selected laboratory tests to evaluate menopause.
4. Assess the risk of osteoporosis by history, physical examination and testing.
5. Interpret the results of other screening tests that should be performed in menopausal patients.
6. Diagnose and manage sexual dysfunction in menopausal patients.
TARGET AUDIENCE
This activity is designed to meet the educational needs of resident physicians in obstetrics and gynecology and other related specialties.
ACGME COMPETENCIES
Medical Knowledge
Patient Care
Interpersonal and Communication Skills
SUCCESSFUL COMPLETION REQUIREMENTS
Successful completion of this educational activity requires the learner to:
· View a course overview page, containing all CME and disclosure information, including acknowledgement of commercial support and disclosure of unlabeled use, prior to the start of each module.
· Complete a 10-question pre-exam prior to the module. Learners should note any pre-exam questions answered incorrectly for clarification during module study.
· Be given the option of downloading a printed syllabus containing the presentation and narrative.
· Participate in the interactive activity: Audio narration is synchronized with PowerPoint presentation that can be advanced, stopped or reversed as desired.
· Complete a 10-question post-exam, with feedback of correct/incorrect answers, scoring a minimum of 70% in two attempts.
· Complete the evaluation survey.
· Print certificate of completion.
DISCLOSURES FOR PLANNERS
Nancy A. Bowers, BSN, RN, MPH – Nothing to Disclose
Andrew R. La Barbera, PhD, HCLD – Nothing to Disclose
Richard H. Reindollar, MD – Nothing to Disclose
DISCLOSURES FOR FACULTY
Ruben J. Alvero, MD – Nothing to Disclose
Paula Amato, MD – Nothing to Disclose
Alicia Y. Armstrong, MD – Nothing to Disclose
Valerie Baker, MD – Institutional Support from IBSA
Bruce R. Carr, MD – Research support from Wyeth, Neurocrine, Boehringer Ingelheim; Consultant for Novo Nordisk
Marcelle I. Cedars, MD – Nothing to Disclose
Bradley S. Hurst, MD – Nothing to Disclose
Helen Kim, MD – Nothing to Disclose
Erica Johnstone, MD – Nothing to Disclose
Emily Jungheim, MD – Consultant for Abbvie, Genentech, Spectrum, Celgene
Lawrence C. Layman, MD – Nothing to Disclose
Richard Legro, MD – Consultant: Euroscreen; Astra Zeneca; Takeda; Clarus Therapeutics; Grant/Research: Astra Zeneca, Ferring
Meredith Loveless, MD – Nothing to Disclose
Elizabeth McGee, MD – Nothing to Disclose
Patricia M. McShane, MD – Consultant, World Egg Bank
Shona C. Murray, MD - Consultant, World Egg Bank
Steven T. Nakajima, MD –Consultant, research support, speaker’s bureau for Warner Chilcott; Stockholder for IntegraMed
Genevieve Neal-Perry, MD, PhD – Nothing to Disclose
Linda R. Nelson, MD, PhD – Nothing to Disclose
Lubna Pal, MBBS, MS – Research grant from Ferring
Staci E. Pollack, MD – Nothing to Disclose
Robert W. Rebar, MD – Nothing to Disclose
Nanette Santoro, MD – Consultant for QuatRx
James H. Segars, MD – Nothing to Disclose
Cynthia Sites, MD – Nothing to Disclose
Anne Steiner, MD – Nothing to Disclose
Mary D. Stephenson, MD, MSc – Consultant for NoraTherapeutics
Michael Thomas, MD – Consultant: Teva
Kim L. Thornton, MD – Consultant for Parexel
Kimberly Thornton, MD – Nothing to Disclose
Lynn Westphal, MD – Nothing to Disclose
Ellen Wilson, MD – Nothing to Disclose
Bo Yu, MD – Nothing to Disclose
It is the policy of the ASRM to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors participating in this activity were required to disclose any relationships they may have with commercial entities whose products or services are used to treat patients so that participants may evaluate the objectivity of the presentations. The content and views presented in this activity are those of the faculty/authors and do not necessarily reflect those of the ASRM or CREOG. Any discussion of off-label, experimental, or investigational use of drugs or devices will also be disclosed. The disclosure statements were reviewed by the Subcommittee for Standards of Commercial Support of the CME Committee of ASRM and any perceived conflicts of interest were resolved in accordance with the policies of the ACCME.
STATEMENT OF SUPPORT
No commercial support has been provided for this activity.